The PE Ratio as of September 2024 (TTM) for Affimed N.V. (AFMD) is -0.65

According to Affimed N.V.’s latest financial reports and current stock price. The company's current PE Ratio is -0.65. This represents a change of -37.37% compared to the average of -1.04 of the last 4 quarters.

Affimed N.V. (AFMD) Historical PE Ratio (quarterly & annually)

How has AFMD PE Ratio performed in the past?

The mean historical PE Ratio of Affimed N.V. over the last ten years is -56.06. The current -0.65 PE Ratio has changed 15.94% with respect to the historical average. Over the past ten years (40 quarters), AFMD's PE Ratio was at its highest in in the March 2021 quarter at 138.72. The PE Ratio was at its lowest in in the March 2015 quarter at -24.43.

Affimed N.V. (AFMD) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Affimed N.V. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Affimed N.V. (AFMD) Average PE Ratio

How has AFMD PE Ratio performed in the past?

The current PE Ratio of Affimed N.V. (AFMD) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Affimed N.V. (AFMD) PE Ratio vs. Peers

How is AFMD’s PE Ratio compared to its peers?

Affimed N.V.’s PE Ratio is less than TCR2 Therapeutics Inc. (-0.44), greater than Pieris Pharmaceuticals, Inc. (-0.93), greater than ADC Therapeutics SA (-1.20), less than Agenus Inc. (-0.47), less than X4 Pharmaceuticals, Inc. (7.41), greater than Terns Pharmaceuticals, Inc. (-6.06), greater than Day One Biopharmaceuticals, Inc. (-7.39), greater than PDS Biotechnology Corporation (-2.64), greater than Inozyme Pharma, Inc. (-3.48), greater than Leap Therapeutics, Inc. (-1.83), greater than Adaptimmune Therapeutics plc (-3.82), greater than Corvus Pharmaceuticals, Inc. (-10.64), less than Aptose Biosciences Inc. (-0.15), less than eFFECTOR Therapeutics, Inc. (-0.00), greater than Elevation Oncology, Inc. (-0.93), greater than Mereo BioPharma Group plc (-18.18), less than Hepion Pharmaceuticals, Inc. (-0.15),

Build a custom stock screener for Affimed N.V. (AFMD) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Affimed N.V. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Affimed N.V. (AFMD) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Affimed N.V. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.